High SOX2 levels predict better outcome in non-small cell lung carcinomas.
BACKGROUND: SOX2 is an embryonic developmental transcription factor, which is important in the development of the respiratory tract. SOX2 overexpression is associated with aggressive disease in several tumor types. However, SOX2 overexpression and gene amplification associates with favorable outcome...
Main Authors: | Vamsidhar Velcheti, Kurt Schalper, Xiaopan Yao, Huan Cheng, Mehmet Kocoglu, Kavita Dhodapkar, Yanhong Deng, Scott Gettinger, David L Rimm |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3631238?pdf=render |
Similar Items
-
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
by: Daniel Carvajal-Hausdorf, et al.
Published: (2019-03-01) -
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
by: Daniel E. Carvajal-Hausdorf, et al.
Published: (2017-10-01) -
Role of immune-checkpoint inhibitors in lung cancer
by: Prantesh Jain, et al.
Published: (2018-01-01) -
Immunotherapy in non-small cell lung cancer: Past, present, and future directions
by: Salman R. Punekar, et al.
Published: (2022-08-01) -
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer
by: Roy S Herbst, et al.
Published: (2022-06-01)